Theralase Launches Laser Rehabilitation Centre



    TORONTO, July 23 /CNW/ - Theralase Technologies Inc. (TSX-V: TLT) today
announced that the Company has launched a Laser Rehabilitation Centre at its
corporate headquarters.
    The Theralase Laser Rehabilitation Centre is a healthcare facility
devoted to the expanding applications of Theralase's laser technology. The
Theralase Centre will provide a training facility for practitioners employing
the Theralase technology, as well as a rehabilitation clinic treating a
variety of pain and tissue conditions, including: nerve, muscle and joint
pain, sports medicine injuries, foot and ankle injuries, post surgical pain,
dermatological conditions, wound healing, inflamed joints such as arthritis,
as well as aesthetic and cosmetic applications and addictions such as smoking.
    Theralase has appointed Dr. Rhonda Mostyn, who has been in private
chiropractic practice since 1995 as the clinic director. Before joining
Theralase, Dr. Mostyn was the Director of the St. Clair West Chiropractic &
Wellness Clinic, a multidisciplinary clinic in Toronto. She has treated
patients with numerous pain conditions, such as: low back, headaches, sports
injuries, foot, knee, chronic joint and muscle pain. Dr. Mostyn has also
developed unique on-site clinics for corporations and fitness facilities. Dr.
Mostyn is registered with the College of Chiropractors of Ontario and is a
member of both the Ontario Chiropractic Association and the Canadian
Chiropractic Association.
    "The Theralase Laser Rehabilitation Centre will act as a Centre of
Excellence for the expanding applications of our laser technology, educating
healthcare practitioners and treating patients wishing to use Theralase's
therapeutic laser systems," said Roger Dumoulin-White, President & CEO of
Theralase Technologies Inc. "Dr. Mostyn has impressive credentials and we
welcome her to lead and grow this new profit centre for the Company."

    Theralase Technologies Inc. designs, develops and manufactures patented,
super-pulsed laser technology used in a wide range of bio-stimulation and
bio-destruction clinical applications. The Theralase technology platform
targets several diverse healthcare sectors: firstly, for non-invasive pain
management and clinical therapy, in hundreds of neural muscular skeletal
conditions, including arthritis; secondly, to bio-stimulate and accelerate
wound care and healing, including bone fracture regeneration; and thirdly,
combining photodynamic compounds with super-pulsed, biofeedback laser
technology to attack specifically targeted cancer, bacteria, viruses and fat
cells.

    This press release contains forward-looking statements which reflect the
Company's current expectations regarding future events. The forward-looking
statements involve risks and uncertainties. Actual results could differ
materially from those projected herein. The Company disclaims any obligation
to update these forward-looking statements.

    The TSX Venture Exchange has not reviewed and does not accept
    responsibility for the adequacy or accuracy of the contents of this
    release.





For further information:

For further information: Roger White, President & CEO, Toll Free:
1-866-THE-LASE (843-5273), Phone: (416) 447-8455, e-mail:
rwhite@theralase.com; Vanessa Beresford, The Equicom Group, Phone: (416)
815-0700 ext 227, e-mail: vberesford@equicomgroup.com

Organization Profile

THERALASE TECHNOLOGIES INC.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890